ANTICOAGULANT SODIUM CITRATE 4% W/V SOLUTION, USP
ANTICOAGULANT SODIUM CITRATE 4% W/V SOLUTION, USP
Approved
DIN Number
02377411
Drug Class
Human
Market Date
Oct 1, 2012
Company
HC
baxter corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02377411
AIG Number0153063001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V07AC BLOOD TRANSFUSION, AUXILIARY PRODUCTS
Product Specifications
Dosage FormSolution
Route of Administration0-Unassigned
AHFS Classification20:12.04.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
SODIUM CITRATE DIHYDRATEActive
Strength: 4 G / 100 ML
Monograph: SODIUM CITRATE DIHYDRATE